Engineering NK Cells Modified With an EGFRvIII-specific Chimeric Antigen Receptor to Overexpress CXCR4 Improves Immunotherapy of CXCL12/SDF-1α-secreting Glioblastoma.
about
EGFR Amplification and Glioblastoma Stem-Like CellsDysregulation of Chemokine/Chemokine Receptor Axes and NK Cell Tissue Localization during DiseasesChimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor ImmunityChallenges and opportunities of allogeneic donor-derived CAR T cellsEnhanced recruitment of genetically modified CX3CR1-positive human T cells into Fractalkine/CX3CL1 expressing tumors: importance of the chemokine gradientDual targeting of glioblastoma with chimeric antigen receptor-engineered natural killer cells overcomes heterogeneity of target antigen expression and enhances antitumor activity and survival.In vitro formation of neuroclusters in microfluidic devices and cell migration as a function of stromal-derived growth factor 1 gradients.Redirected Primary Human Chimeric Antigen Receptor Natural Killer Cells As an "Off-the-Shelf Immunotherapy" for Improvement in Cancer Treatment.Exosomes Derived From Natural Killer Cells Exert Therapeutic Effect in Melanoma.Mesenchymal stromal cells' role in tumor microenvironment: involvement of signaling pathways.Natural Killer Cells: Angels and Devils for Immunotherapy.Genetic engineering of human NK cells to express CXCR2 improves migration to renal cell carcinoma.Chromosomal instability induced by increased BIRC5/Survivin levels affects tumorigenicity of glioma cells.Chimeric antigen receptor (CAR)-transduced natural killer cells in tumor immunotherapy.A Poly(Propyleneimine) Dendrimer-Based Polyplex-System for Single-Chain Antibody-Mediated Targeted Delivery and Cellular Uptake of SiRNA.Next generation natural killer cells for cancer immunotherapy: the promise of genetic engineering.The Role of CXC Chemokine Receptors 1-4 on Immune Cells in the Tumor MicroenvironmentTargeting Chemokines and Chemokine Receptors in Melanoma and Other Cancers
P2860
Q26853549-24DFABB4-8446-4459-B54B-77F23B7D0D0EQ28079140-EE59156E-1822-470A-905F-BC8653E8F54EQ33700795-0F953DC6-8C24-45E3-88D5-48083C1583B4Q36257036-7400E8D3-FCA0-4731-A25E-9261E657AF0BQ36811526-8688E81D-7FE0-4DC9-94C2-1D87AE39D8A7Q36821054-D935D7E3-0308-4CD3-8ED6-9E448227AA1DQ37641121-FCF9CD7A-52EE-4E23-91CF-BE4908200BFBQ38666862-1C70DDCF-B269-40EC-A2A4-929510B91F1FQ38694652-C738037D-5050-46AD-A1D4-6EEA36373CDDQ39368381-CAC3E20F-BADF-47C4-86FA-E73DA6954E43Q41661175-EB95AB7C-7416-45D1-A5E0-C296DAEAD6DDQ41714691-8D79099F-78CF-4FAF-9C9C-4A98026511BCQ47140262-C21CED4F-30FB-42AC-8610-5DE36948431BQ47843897-CAF1B5F9-4F08-4B42-93FE-21046808DD93Q48092346-4F1778BD-383C-4AAC-AFD5-C09D2F625078Q52615722-8E6EB325-C3DA-4D43-9F49-A096AB4E71A2Q57492022-AC24B96D-7804-46E7-9139-409FF55FDF74Q58694964-64176BC2-8AFF-4199-93A7-5FD6164217E6
P2860
Engineering NK Cells Modified With an EGFRvIII-specific Chimeric Antigen Receptor to Overexpress CXCR4 Improves Immunotherapy of CXCL12/SDF-1α-secreting Glioblastoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Engineering NK Cells Modified ...... SDF-1α-secreting Glioblastoma.
@ast
Engineering NK Cells Modified ...... SDF-1α-secreting Glioblastoma.
@en
type
label
Engineering NK Cells Modified ...... SDF-1α-secreting Glioblastoma.
@ast
Engineering NK Cells Modified ...... SDF-1α-secreting Glioblastoma.
@en
prefLabel
Engineering NK Cells Modified ...... SDF-1α-secreting Glioblastoma.
@ast
Engineering NK Cells Modified ...... SDF-1α-secreting Glioblastoma.
@en
P2093
P2860
P1476
Engineering NK Cells Modified ...... SDF-1α-secreting Glioblastoma.
@en
P2093
Alexander Schulte
Gabriele Schackert
Ira Pastan
Katrin Lamszus
Katrin Töpfer
Marc Schmitz
Nadja Müller
Stefanie Tietze
Susanne Michen
P2860
P304
P356
10.1097/CJI.0000000000000082
P50
P577
2015-06-01T00:00:00Z